BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8078585)

  • 1. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell.
    Nelson CA; Petzold SJ; Unanue ER
    Nature; 1994 Sep; 371(6494):250-2. PubMed ID: 8078585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
    Vignali DA; Urban RG; Chicz RM; Strominger JL
    Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and quantitation of a minor determinant of hen egg white lysozyme bound to I-Ak by using peptide-specific immunoaffinity.
    Gugasyan R; Vidavsky I; Nelson CA; Gross ML; Unanue ER
    J Immunol; 1998 Dec; 161(11):6074-83. PubMed ID: 9834091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
    Harding CV; Unanue ER
    Nature; 1990 Aug; 346(6284):574-6. PubMed ID: 2115981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
    Lambert LE; Unanue ER
    J Immunol; 1989 Aug; 143(3):802-7. PubMed ID: 2787347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope.
    Allen PM; Matsueda GR; Evans RJ; Dunbar JB; Marshall GR; Unanue ER
    Nature; 1987 Jun 25-Jul 1; 327(6124):713-5. PubMed ID: 2439915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.
    Viner NJ; Nelson CA; Deck B; Unanue ER
    J Immunol; 1996 Apr; 156(7):2365-8. PubMed ID: 8786292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking.
    Lehmann PV; Cardinaux F; Appella E; Muller S; Falcioni F; Adorini L; Nagy ZA
    Eur J Immunol; 1989 Jun; 19(6):1071-7. PubMed ID: 2787751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116.
    Robadey C; Wallny HJ; Demotz S
    Eur J Immunol; 1996 Jul; 26(7):1656-9. PubMed ID: 8766576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
    van Noort JM; Jacobs MJ
    Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.